Around the world, the COVID 19 pandemic is accelerating with only limited countries managing to flatten the curve, the number of cases in many other parts of the world has continued to reach new highs. Molecular test (RT PCR), the standard diagnosis for COVID 19 has many limitations of quite time consuming, specific equipment and training requirement, and the resulting increase of total cost and burden of diagnosis. The major advantage of using antigen is to reduce the burden of relying on just RT PCR to identify current infection of SARS CoV 2. Antigen testing is useful because even if it’s less sensitive, it is so rapid, convenient and efficient, and the results that are positive will be positive. SGTi-flex is one step, Rapid Immunochromatographic Assay for the qualitative detection of specific antigens to SARS CoV 2 present in human nasopharynx.